|
|
|
|
LEADER |
00000cam a2200000Mu 4500 |
001 |
EBOOKCENTRAL_on1121125762 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr |n|---||||| |
008 |
190928s2019 nju o 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d REDDC
|d OCLCF
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCL
|
066 |
|
|
|c (S
|
020 |
|
|
|a 9781119252955
|
020 |
|
|
|a 1119252954
|
035 |
|
|
|a (OCoLC)1121125762
|
050 |
|
4 |
|a RC636
|b .M654 2020
|
082 |
0 |
4 |
|a 616.15
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Provan, Drew.
|
245 |
1 |
0 |
|a Molecular Hematology
|
250 |
|
|
|a 4th ed.
|
260 |
|
|
|a Newark :
|b John Wiley & Sons, Incorporated,
|c 2019.
|
300 |
|
|
|a 1 online resource (420 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
505 |
8 |
|
|a 2 Stem cellsIntroduction; Stem cell definitions and distinctions; Hematopoietic stem cell concepts and their origin; The cellular compartment model; Models of lineage commitment; Molecular regulation of hematopoiesis; Cell-intrinsic regulators of hematopoiesis; Cell-extrinsic regulators; Components of the hematopoietic microenvironmental niche; Trafficking of primitive hematopoietic cells; Hematopoietic ontogeny; Homing and engraftment of HSCs following infusion; Egress of HSCs from bone marrow under physiological conditions; Manipulating HSCs for clinical use; Mobilization of HSCs
|
505 |
8 |
|
|a Isolating stem cells for manipulationSummary; Further reading; 3 The genetics of acute myeloid leukemias; Introduction; AML with recurrent cytogenetic abnormalities; Core-binding factor leukemias; Acute promyelocytic leukemia; KMT2A gene rearrangements (11q23); Other rare chromosomal translocations; Numerical chromosomal abnormalities; Molecular genetic aberrations not detectable by conventional cytogenetics; Driver gene mutations; Activated signaling; Myeloid transcription factors; Tumor suppressors; Spliceosome genes; Cohesin complex genes; DNA methylation; Chromatin modifiers
|
505 |
8 |
|
|a AML therapies and MRD monitoring targeted by geneticsSummary; Further reading; 4 Molecular diagnostics and risk assessment in myeloid malignancies; Introduction; Clonal hematopoiesis; Myelodysplastic syndromes; Acute myeloid leukemia; General methodology of cytogenetic analysis in hematological malignancies; Methods of detection; Genetic and clinical consequences of chromosomal translocation; Karyotypic evolution; Clinical implications; Treatment selection; Recurrent cytogenetic abnormalities in MDS; Recurrent cytogenetic aberrations in AML
|
500 |
|
|
|a Therapy-related chromosomal aberrations in secondary AML
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Blood
|x Diseases
|x Molecular aspects.
|
650 |
|
6 |
|a Sang
|x Maladies
|x Aspect moléculaire.
|
650 |
|
7 |
|a Blood
|x Diseases
|x Molecular aspects
|2 fast
|
700 |
1 |
|
|a Gribben, John.
|
758 |
|
|
|i has work:
|a Molecular hematology (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFPdxy4R4v4wqwTC4QvpGd
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Provan, Drew.
|t Molecular Hematology.
|d Newark : John Wiley & Sons, Incorporated, ©2019
|z 9781119252870
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5904671
|z Texto completo
|
880 |
0 |
|
|6 505-00/(S
|a Intro; Molecular Hematology; Dedication; Contents; Contributors; Preface to the fourth edition; Further reading; Acknowledgments; 1 Beginnings: the molecular pathology of hemoglobin; Historical background; The structure, genetic control, and synthesis of normal hemoglobin; Structure and function; Genetic control of hemoglobin; Gene action and globin synthesis; Regulation of hemoglobin synthesis; Regulation of developmental changes in globin gene expression; The molecular pathology of hemoglobin; The β thalassemias; Defective β globin gene transcription
|
880 |
8 |
|
|6 505-00/(S
|a Mutations that cause abnormal processing of mRNAMutations that result in abnormal translation of β globin mRNA; Unstable β globin chain variants; The α thalassemias; Rarer forms of thalassemia and related disorders; Genotype-phenotype relationships in the thalassemias; The β thalassemias; Phenotypic diversity; The α thalassemias; Structural hemoglobin variants; Molecular pathology; Genotype-phenotype relationships; Molecular aspects of the high frequency of the hemoglobin variants; Molecular aspects of the prevention and management of the hemoglobin disorders; Postscript; Further reading
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5904671
|
994 |
|
|
|a 92
|b IZTAP
|